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12S Abstracts May Supplement 2013Objectives: Arteriovenous ﬁstulas (AVF) are the
preferred access for patients who require hemodialysis.
However, some AVFs require additional surgery to
augment maturation. This study determined the effective-
ness of AVF revision and the clinical characteristics of
patients with poorly maturing ﬁstulas.
Methods: All AVFs performed over a 5-year period
(January 2006-December 2011) were reviewed, classiﬁed
as radial-cephalic (RC), brachial-cephalic (BC), brachial-
basilic transposition (BVT), and brachial-brachial (BB).
Technical factors and co-morbidities for patients with
AVFs that matured without assistance were compared
with ﬁstulas that required revision or were abandoned.
Data were evaluated on a per-patient basis (c2 and t-test,
P value <.05)
Results: 292 AVFs were created in 250 patients.
134/250 ﬁstulas (53.6%) matured without assistance
within an average of 71 days. Patients with AVFs that
matured without revision were more likely to be male
(60.6% vs 42.1%; P < .01), have a lower BMI (26.9 vs
29.8; P < .01), and a larger preoperative vein diameter
(3.83 mm vs 3.42 mm; P < .02). 54 of 116 non-matured
AVFs were revised (70% RC, 26% BC, 4% BVT). The
more common revisions were branch ligation (52%),
superﬁcial transposition (31%), and anastomotic revision
(30%). 89% required one, 9% two, and 2% required three
revisions to achieve maturation. Average time from index
AVF creation to maturation in revised patients was 209
days. 42/54 patients (79.2%) developing a usable ﬁstula,
increasing the overall maturation rate to 70.4%. The
most common cause for abandoning a non-mature ﬁstula
was thrombosis (62%).
Conclusions: Surgical revision for poorly maturing
AVFs increases overall ﬁstula maturation rates as much
as 17%.
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disclose; A. A. Price: Nothing to disclose.Fig. Vascular electronic discharge follow-up form.PVSS18.
Decreased Readmission Is a Phone Call Away
Heather Lee, Faisal Aziz, Judith Cook, David Han, Robert
Atnip, Amy B. Reed. Heart and Vascular Institute, Pa State
College of Medicine, Hershey, Pa
Objectives: A 3% penalty in Medicare reimbursement
for patients readmitted with MI, CHF, and pneumonia
began October 1, 2012. Recent data have documented
a 24% readmission rate for Medicare beneﬁciaries under-
going vascular surgery, a rate second only to those patients
with an index admission for congestive heart failure. We
hypothesized that Vascular RN phone calls to address
patient concerns would help decrease readmission.
Methods: A Vascular RN received a daily discharge
list generated from the electronic health record (EHR)
detailing all patients discharged from the vascular service
from 3/1/-12/1/2012. Phone calls were made on
discharge days (DD) 1 and 7. Information was col-
lected prospectively (Fig). Readmission rates within30 days were compared to 2011. c2 test was used for
comparisons.
Results: A total of 568 patients were discharged
during this time period with 8.8% readmitted. Readmission
rate during the same months of preceding year was 14.5%.
Among the discharged patients, 71.6% were successfully
contacted by phone. Readmission rate for those with
a follow-up phone call was 7.25% vs 12.5% for those who
did not receive one (P .04). Lower extremity bypass
(12.9%) and major amputation (13.3%) patients were
most frequently readmitted.
Conclusions: Utilization of a Vascular RN for phone
contact on DD 1 and 7, to address concerns appears to
be an effective strategy that may help reduce readmission.
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Objectives: Patient-centric value is deﬁned as health
outcome achieved per dollar spent, however current reim-
bursement is predicated on volume of service, not value
achieved. The purpose of this study is to examine the
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Volume 57, Number 5S Abstracts 13Srelationship between hospital value and patient value using
contemporary and hypothetical payment schemas for aortic
surgery.
Methods: Ten-year clinical and inﬂation-corrected
ﬁnancial data were collected for patients undergoing
abdominal aortic aneurysm repair (AAA). Comorbid
proﬁle was quantiﬁed using a modiﬁed Charlson Comor-
bidity Index (CCI). Patient value [freedom from complica-
tion (d)/total charges ($)] was compared to a novel
measure of hospital value [contribution margin ($)/bed-
day (d)] via regression analyses.
Results: 509 patients had complete clinical and ﬁnan-
cial data to be included in the analysis. The average reim-
bursement was $21 k and comparison of patient value
(range, 0-19 d/$10k) to hospital value (range, 36 k to
+31 k $/d) yields a weak correlation (r2 ¼ .027; Fig).
Reimbursement schema were hypothesized utilizing base
payment ($5k-$20k), value multiplier and CCI risk adjust-
ment keeping total expenditure static. With decreasing base
payment ($20k, $15k, $10k, $5k) correlation between
hospital value and patient value improved (r2 ¼ .116,
0.202, 0.273 and 0.322; $10k base payment results shown
in the Fig).
Conclusions: Contemporary aortic surgery pay-
ment fails to reward healthcare systems for patient value.
A risk-adjusted value-based payment reconciles this
issue and rewards healthcare systems for high value patient
care.
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Objectives: The impact of outpatient diabetic care on
the outcome of lower extremity revascularization (LER)
for critical limb ischemia (CLI) is unknown. We hypothe-
sized that outcomes following LER in diabetics with CLI
might be improved by high-quality outpatient diabetic
care, as indexed by the annual rate of cholesterol
(CHOL) and HbA1c testing.
Methods: We studied 84,653 diabetic patients with
CLI (52% male, 15% black, mean age 76 yrs) who under-
went open and endovascular LER using Medicare claims
(2004-2007). The Healthcare Effectiveness Data & Infor-
mation Set (HEDIS) quality indicators for annual CHOL
and HbA1C testing were used as a proxy for quality of dia-
betic care. We examined relationships between frequency
of diabetic testing, amputation-free survival (AFS), and
major adverse limb events (MALE) across all US hospital
referral regions.
Results: There was signiﬁcant regional variation in
annual HbA1C and CHOL testing across the U.S. (84%
highest quartile vs 60% lowest quartile; P < .01).
Compared with the lowest quartile of diabetic testing,
patients undergoing LER in regions with the highest quar-
tile of diabetic testing had signiﬁcantly better AFS, MALE,
and mortality (Table). These beneﬁts persisted more than 2e-based (green) aortic surgery reimbursement.
